Navigation Links
Caliper Life Sciences Announces IVIS Spectrum CT
Date:8/31/2011

HOPKINTON, Mass., Aug. 31, 2011 /PRNewswire/ -- Caliper Life Sciences, Inc. (NASDAQ: CALP) today announced the availability of the IVIS Spectrum CT, a breakthrough preclinical imaging system that integrates, into a single instrument system, advanced optical imaging and low dose microCT (micro computed tomography).  Spectrum CT enables simultaneous molecular and anatomical longitudinal studies, providing researchers with vital, unparalleled insights into complex biological systems in small animal models used to develop new, clinically translatable discoveries.  A broad array of applications exist for the new instrument, with musculoskeletal, vascular, oncology, phenotyping, cardiovascular and respiratory disease among those areas particularly enabled by the integration of optical and microCT imaging.

The Spectrum CT expands upon the versatility and advanced optical features of the Caliper IVIS and Maestro platforms, the leading preclinical optical imaging technologies with over 1250 instruments placed worldwide.  The system offers powerful, flexible and exquisitely sensitive optical molecular imaging integrated with complementary, ultra-fast, low-dose microCT anatomical imaging.  Features include optical sensitivity capable of achieving detection of a few cells and 3-dimensional reconstructions of optical molecular bioluminescence and fluorescence signals, integrated with 3-dimensional anatomical microCT images.  Designed for high-throughput, quantitative, non-invasive longitudinal analysis of large cohorts of animals, Spectrum CT enables new, clinically translatable insights.  Regarding one example application, Lloyd Miller, MD., PhD., Assistant Professor at UCLA Departments of Medicine and Orthopaedic Surgery commented, "The Spectrum CT provided extraordinary 3-dimensional images of bacteria and infection-induced inflammation in implant biofilms and the anatomical interactions between bone and the implant. This is achieved noninvasively in the same mice and in real-time. The instrument represents a major advance in the field of in vivo imaging and we are excited about the opportunity to use the Spectrum CT for our research."  

"IVIS Spectrum CT is a revolutionary platform, the result of continued innovation by Caliper in response to the unmet research and translational needs of our customers," said Kevin Hrusovsky, President and Chief Executive Officer of Caliper Life Sciences. "The fertile preclinical research arena continues to push the boundaries to our understanding of disease, while directly impacting development of new personalized therapies and related companion diagnostics.  Our focus on high-quality, quantitative imaging and analysis systems enables critical research by providing insight and context to functional and anatomical events that are relevant to clinical research, drug development and diagnostics."

Caliper will deliver technical presentations on the IVIS Spectrum CT on September 6 at Caliper's West Coast COG meeting and will unveil the platform at the World Molecular Imaging Congress in San Diego on September 7 (Booth 102). For additional information regarding IVIS Spectrum CT please visit: www.CaliperLS.com/SpectrumCT.  Visit www.CaliperLS.com/ivis to learn more about Caliper's complete line of in vivo imaging solutions including optical and microCT systems, along with a full suite of applications and reagents.

About Caliper Life Sciences

Caliper is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results, enabling researchers to translate those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, tissue microscopy, preclinical imaging technologies, and discovery & development outsourcing solutions. For more information please visit www.caliperLS.com.


'/>"/>
SOURCE Caliper Life Sciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Caliper Life Sciences to Present at Stifel Nicolaus Healthcare Conference 2011
2. Caliper and Carestream Settle Lawsuits
3. Caliper Life Sciences Reports Second Quarter 2011 Results
4. Caliper Life Sciences to Present at the Leerink Swann Life Science Tools & Diagnostics Roundtable
5. Caliper Life Sciences Second Quarter Results Conference Call Notice
6. Caliper Life Sciences to Ring The NASDAQ Stock Market Opening Bell on Tuesday, July 19
7. Roche NimbleGen and Caliper Collaborate to Offer Automated Target Enrichment Pipeline Solution for Next-Generation Sequencing
8. Caliper Owners Group Meeting Showcases Transformative Technologies for Advancing Personalized Medicine
9. Caliper Life Sciences to Present at Jefferies 2011 Global Healthcare Conference
10. Caliper Life Sciences to Webcast Investor Session of Open House
11. Caliper Life Sciences Reports First Quarter 2011 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2016)... SAN FRANCISCO, Calif. , May 19, 2016 /PRNewswire/ ... a biopharmaceutical company developing novel therapeutics for the treatment ... announced that new GBT440 data will be presented in ... 21 st Congress in Copenhagen ... ongoing Phase 1/2 GBT440-001 study in sickle cell disease ...
(Date:5/19/2016)... 2016 BioLineRx Ltd. (NASDAQ/TASE: BLRX) ... treatment of multiple cancer and hematological indications, will be ... abstract titled " Clinical response in relapsed/refractory AML patients ... BL-8040, a potent CXCR4 antagonist; results of a Phase ... at the European Hematology Association 21st Congress, to be ...
(Date:5/19/2016)... CAMBRIDGE, Massachusetts , May 19, 2016 ... pharmaceuticals and diagnostics based on the gut microbiome, is pleased ... Cambridge, MA to support its operations ... office is located at Kendall Square, the heart of ... global hub for transforming scientific insights into new drugs. The ...
Breaking Medicine Technology:
(Date:5/24/2016)... Linda, CA (PRWEB) , ... May 24, 2016 ... ... fluorescent cell imaging; high content imaging; multiplex immunoassays are widely used for cell ... important for labs to maximize their quality and efficiency in these areas. , ...
(Date:5/23/2016)... ... 23, 2016 , ... On the occasion of his 25th Anniversary of changing ... loss process: , New patients have a consultation and evaluation (done by Dr. Ferdico ... , Body Composition Analysis, There are 15 things that each patient gets checked for, ...
(Date:5/23/2016)... ... 23, 2016 , ... According to an article published May 11th ... birth of her son, Rockwell Lloyd Liu, and notes that gestational surrogacy helped make ... Bill” star explains that, as a career oriented single woman, gestational surrogacy made parenthood ...
(Date:5/23/2016)... ... May 23, 2016 , ... NYDNRehab, a New York City-based ... athletes. This is the first time this type of technology, which was developed by ... to the public in New York. , With over 10 million sport injuries ...
(Date:5/23/2016)... ... May 23, 2016 , ... California State University Northridge ... quality of life and is currently focusing on ways to improve how people ... tested through research to find out whether watching them could have a significant ...
Breaking Medicine News(10 mins):